Review article: Immunological determinants that may affect the Helicobacter pylori cancer risk

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue SUPPL. 1, 1998, Pages 83-90

  Blanchard, T G ^a   Czinn, S J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON ANTIBODY; INTERFERON ANTIBODY; INTERLEUKIN 12 ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL MODEL; ATROPHIC GASTRITIS; BACTERIAL VIRULENCE; CANCER RISK; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HELICOBACTER PYLORI; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; INBRED STRAIN; MOUSE; NONHUMAN; PATHOGENICITY; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER;

ANIMALS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MICE; PHENOTYPE; STOMACH NEOPLASMS;

EID: 0031929035     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1998.00010.x     Document Type: Review

References (44)

1. Marshall M J, Warren R J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
2. Marshall B J, McGechie D B, Francis G J, Utley P J. Pyloric campylobacter serology. Lancet 1984; ii: 281.
3. Drumm B, Sherman P, Cutz E. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987; 316: 1557-61.
4. Blaser M J. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987; 93: 371-83.
5. Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-25.
6. Marshall B J, Armstrong J A, McGechie D B. Attempt to fulfill Koch's postulate for pyloric Campylobacter. Med J Aust 1985; 142: 436-9.
7. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-9.
8. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Cancer 1990; 66: 2569-74.
9. Forman D, Newell D G, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302-5.
10. Forman D, Sitas F, Newell D G, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-11.
11. Nomura A, Stemmermann G N, Chyou P H, Kato I, Perez-Perez G I, Blaser M J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
12. Parsonnet J, Vandersteen D, Goates J, Silbey R K, Pritkin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83: 640-3.
13. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
14. WHO. Infection with Helicobacter pylori. In: Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer, 1994; 61: 177-241.
15. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
16. Sarosiek J, Slomiany A, Slomiany B L. Evidence for weakening of gastric mucus intregity by Campylobacter pylori. Scand J Gastroenterol 1988; 23: 585-90.
17. Grisham M B, Jefferson M M, Melton D F, Thomas E L. Chlorination of endogenous amines by isolated neutrophils: amonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem 1984; 259: 10404-13.
18. Suzuki M, Miura S, Suematsu M, et al. Helicobacter pylori elicits gastric mucosal cell damage associated with neutrophil-derived toxic oxidants. Eur J Gastroenterol Hepatol 1993; 5 (Suppl. 1): S35-S39.
19. Davies G R, Simmonds N J, Stevens T R J, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
20. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88: 1870-5.
21. Leunk R D, Johnson P T, David B C, Kraft W G, Morgan D R. Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-9.
22. Cover T J, Blaser M J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570-5.
23. Telford J L, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-8.
24. Cover T L, Cao P, Lind C D, Tham K T, Blaser M J. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-12.
25. Phadnis S H, Ilver D, Janzon L, Normark S, Westblom T U. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 1994; 62: 1557-65.
26. Cover T L, Dooley C P, Blaser M J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-10.
27. Crabtree J E, Taylor J D, Wyatt J I, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332-5.
28. Crabtree J E, Wyatt J I, Sobala G M, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34: 1339-43.
29. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994; 56: 56-60.
30. Cover T L, Blaser M J. Helicobacter pylori: A bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. ASM News 1995; 61: 21-26.
31. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 120 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5.
32. Xiang Z, Censini S, Bayeli P F, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8.
33. Atherton J C, Peek R Jr, Tham K T, Cover T L, Blaser M J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-9.
34. Tummuru M K, Sharma S A, Blaser M J. Helicobacter pylori picB, a homolog of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995; 18: 867-76.
35. Peek R M, Thompson S A, Atherton J C, Blaser M J, Miller J J. Expression of IceA, a novel ulcer-associated H. pylori gene, is induced by contact with gastric epithelial cells and is associated with enhanced mucosal IL-8. Gut 1996; 39 S2: A71.
36. Peek R M, Thompson S A, Atherton J C, Blaser M J, Miller G G. Expression of a novel ulcer-associated H. pylori gene, ICEA, following adherence to gastric epithelial cells (Abstract). Gastroenterology 1996; 110: A225.
37. Blanchard T G, Czinn S J, Nedrud J G, Redline R W. Helicobacter-associated gastritis in SCID mice. Infect Immun 1995; 63: 1113-15.
38. Sakagami T, Shimoyama T, O'Rourke J, Lee A. Back to the host: Severity of inflammation induced by Helicobacter felis in different strains of mice. Am J Gastroenterol 1994; 89: 1345 (Abstract).
39. Mohammadi M, Redline R, Nedrud J, Czinn S. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 1996; 64: 238-45.
40. Sakagami T, Dixon M, O'Rourke J, et al. Atrophic gastric changes in both H. felis and H. pylori infected mice are host dependent and separate from antral gastritis. Gut 1996; 39: 639-48.
41. Mohammadi M, Nedrud J, Czinn S. IL-12 treatment induces susceptibility to Helicobacter-associated gastritis in the resistant BALB/c mouse strain. Gut 1996; 39 (Suppl. 2): A59 (Abstract).
42. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a DTH response in the stomachs of mice. J Immunol 1996; 156: 4729-38.
43. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn S. Murine CD4 T cell responses to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997; 113:
44. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.